Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles

Abstract

Among kidney transplant recipients, the treatment of choice for acute T cell-mediated rejection (TCMR) with pulse steroids or antibody protocols has variable outcomes. Some rejection episodes are resistant to an initial steroid pulse, but respond to subsequent antibody protocols. The biological mechanisms causing the different therapeutic responses are not currently understood. Histological examination of the renal allograft is considered the gold standard in the diagnosis of acute rejection. The Banff Classification System was established to standardize the histopathological diagnosis and to direct therapy. Although widely used, it shows variability among pathologists and lacks criteria to guide precision individualized therapy. The analysis of the transcriptome in allograft biopsies, which we analyzed in this study, provides a strategy to develop molecular diagnoses that would have increased diagnostic precision and assist the development of individualized treatment. Our hypothesis is that the histological classification of TCMR contains multiple subtypes of rejection. Using R language algorithms to determine statistical significance, multidimensional scaling, and hierarchical, we analyzed differential gene expression based on microarray data from biopsies classified as TCMR. Next, we identified KEGG functions, protein–protein interaction networks, gene regulatory networks, and predicted therapeutic targets using the integrated database ConsesnsusPathDB (CPDB). Based on our analysis, two distinct clusters of biopsies termed TCMR01 and TCMR02 were identified. Despite having the same Banff classification, we identified 1933 differentially expressed genes between the two clusters. These genes were further divided into three major groups: a core group contained within both the TCMR01 and TCMR02 subtypes, as well as genes unique to TCMR01 or TCMR02. The subtypes of TCMR utilized different biological pathways, different regulatory networks and were predicted to respond to different therapeutic agents. Our results suggest approaches to identify more precise molecular diagnoses of TCMR, which could form the basis for personalized treatments.

Comprehensive analysis of circRNA expression profiles in humans by RAISE

“…Approximately 95% of these reads were aligned to the human reference genome (hg38). Multidimensional scaling (MDS) ( 47 ) analysis showed that the HCC samples were distinct from normal and adjacent non-cancerous tissue samples ( Fig. 3A ).…”

Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing

“…Paired samples A2 and T2 were filtered out because of the small amount of data obtained. Multidimensional scaling analysis (MDS) was performed to show that the tumor samples were distinct from the adjacent non-cancerous tissue samples [ 10 ]. Four samples (A5, T5, T6, and T14) were found to be potentially misidentified and were excluded from further analysis ( Supplementary Figure 1 ).…”

The Value of Single-cell Technologies in Solid Organ Transplantation Studies

“…These studies are therefore hard to generalize and do not capture the heterogeneity within rejection types. 59,60 In addition, several studies have used biopsies from patients with mixed rejection, making it hard to make conclusions on whether findings are specific for mixed rejection, TCMR, or AMR. Finally, most studies have focused on kidney transplantations, so it remains to be determined whether these findings can be extrapolated to transplantations with other organs as well.…”